FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (rm. 1503), Silver Spring, MD 20993
“To allow FDA to obtain patient perspectives on the impact of autism on daily life as well as patient views on treatment approaches for autism.”
People interested in attending the meeting are required to register for the event. Registration closes on April 24, 2017. For additional information on registration, view FDA’s supplementary information.
In addition to the meeting, FDA is also announcing an opportunity for public comment on the topic. The deadline to submit comments is July 5, 2017. Electronic comments must be submitted on or before July 5th, and written paper submissions must be postmarked is on or before that date.